Hamlet Pharma Q1 Interim Report July 2022 – September 2022
Opening remarks The HAMLET family of drug candidates has remarkable effects and continues to show great promise for the prevention and treatment of cancer. Alpha1H kills tumor cell efficiently and attacks tumor tissue in patients with bladder cancer. A unique mechanism of action permits Alpha1H to target the tumor without damaging healthy bladder tissue. In bladder cancer patients, the tumor responds by releasing large numbers of tumor cells and tumor fragment into the urine, which is an efficient way of removing tumor tissue without causing a toxic effect. These positive findings suggest